Dyadic International, Inc.
Dyadic International, Inc.
Dyadic International, Inc.
DYAI
DYAI
Nasdaq
Health Services
Medical/Nursing Services
1.19
USD
-0.02
-1.65%
Cerrado: 07-24 20:00 (UTC+0)
1.19
USD
+0.0559
+4.70%
Después del cierre: 07-25 00:00 (UTC+0)

DYAI Estadísticas clave

Alto
1.26
Abrir
1.21
Volumen
105.18K
Bajo
1.12
Cierre anterior
1.21
Valor negociado
125.54K
Máx. 52 sem.
1.60
Volumen rel.
0.371
Amplitud (%)
11.49%
Mín. 52 sem.
0.65
Tasa de rotación
0.29%
Cap. de Mercado
43.36M
PER (TTM)
--
PER (Anual)
--
P/B
-106.35
P/S
11.39
Beneficio por acción (BPA)
-0.214
Dividendo (TTM)
0
Rentabilidad por dividendo
0.00%
Acciones en circulación
36.43M
Moneda
USD

DYAI Rendimiento del Precio

7 día
30 día
90 día
180 día
En lo que va del año
1 Año
DYAI Distribución del flujo de dinero
DYAI Volumen diario de ventas en corto
DYAI Historial de short interest
As of 2026-07-26, the Dyadic International, Inc. (DYAI) stock price today is 1.19. Based on this price, the company has a market capitalization of $43.36M, with a P/E ratio of --. On 2026-07-26, DYAI traded between 1.12 and 1.26. Today’s stock price is 6.25% above the daily low and 5.56% below the daily high, placing DYAI cerca de la mitad de its most recent trading range. Trading volume currently stands at 105.18K, compared with an average daily volume of 283.91K. This suggests that trading activity is significativamente por debajo de su nivel habitual than usual. Over the past year, Dyadic International, Inc. shares have traded between 0.65 and 1.60. At today’s price, DYAI is 83.08% above its 52-week low and 25.63% below its 52-week high.
Nombre empresa
Dyadic International, Inc.
Sector
Health Services
Industria
Medical/Nursing Services
Intercambios
Nasdaq
Número de empleados
5
Tamaño del lote
100
Sitio oficial
Moneda
USD
Dyadic International Inc is a biotechnology platform company. It has developed a gene expression platform for producing commercial quantities of industrial enzymes and other proteins and has licensed this technology to third parties, such as Abengoa Bioenergy, BASF, Codexis and others, for use in industrial (non-pharmaceutical) applications. This technology is based on the Thermothelomyces heterothallica fungus, which the company named C1.

DYAI FAQ

Buscar divisas
Más